• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Edgewise

Edgewise Therapeutics

A Movement in Muscle

  • Clinical Trials
  • Careers
  • Investors & News
  • Company
    • Company Overview
    • Leadership Team
    • Careers
    • Contact Us

    Our vision is to improve the lives of patients and families suffering from serious muscle diseases by building the world’s leading muscle-focused company.

    Learn More

  • Science
    • Science Overview
    • Pipeline
    • Sevasemten
    • EDG-7500
    • EDG-15400
    • Clinical Trials
    • Posters & Presentations

    All of us at Edgewise are committed to developing new medicines for people facing serious muscle diseases with unmet medical needs.

    Explore our Science

  • Disease Areas
    • Disease Areas Overview
    • Muscular Dystrophy
    • Cardiovascular Diseases

    Learn more about how our science is driving a new understanding of muscle and its potential to transform human health.

    Explore Muscle

  • Patients & Families
    • Patients & Families Overview
    • Support for Becker
    • Support for Duchenne
    • Support for HCM
    • Patient Stories

    We honor the experience of individuals and families living with and facing the challenges of serious muscle disease.

    Read their Stories

  • Investors & News
    • Corporate Profile
    • News
    • Events & Presentations
    • Analyst Coverage
    • Stock Info
      • Stock Quote
      • Stock Chart
      • Historical Stock Quote
      • Investment Calculator
    • Financials
      • Quarterly Results
      • SEC Filings
    • Governance
      • Governance Documents
      • Committee Composition
    • Resources
      • Investor FAQs
      • Investor Email Alerts
      • Investor Contacts
HomeDisease Areas

Disease Areas

Dedicated Science for Serious Muscle Diseases

At Edgewise, muscle science moves us forward; its promise to solve significant unmet need in patient communities drives our research and inspires our thinking as we pursue new possibilities in therapeutic development for serious muscle diseases.

Start with the patient.
Follow the science.

Transformative science has no boundaries; it can surprise us, fascinate us, even challenge us as it overturns conventional, comfortable ways of thinking. When science starts with the core problem at the human level, it reveals fundamental truths about our world and ourselves, pointing towards new directions in our quest to bring life-changing medicines to people living with serious muscle diseases.

Muscle:  a critiCal organ with strong therapeutic potential

Muscle plays a vital role in human health. It’s an extraordinary organ that connects us to the world, powers our most essential organs, plays a key role in metabolism, regeneration, and growth, and helps us experience everyday through our senses and movement. But when the muscle, including the skeletal or cardiovascular muscle, is affected by serious disease, our bodies can be limited—in our health, our mobility, and in our ability to live to our true potential.

Our Focus:

Serious Muscle Diseases With Life-limiting Impact

All of us at Edgewise are committed to developing new medicines for people facing serious muscle diseases with unmet medical needs. Our current focus is on conditions affecting skeletal and cardiovascular muscle, including muscular dystrophies like Becker and Duchenne, and cardiovascular conditions like Hypertrophic Cardiomyopathy (HCM) and Heart Failure (HF).

Explore our science

Cardiovascular Diseases

Some cardiac diseases, including HCM and HF, cause diastolic dysfunction where the stiff heart does not relax properly and therefore struggles to fill with blood limiting its ability to work well. Learn more about diastolic dysfunction and its role in HCM and HF.

Learn more about HCM & HF

Muscular Dystrophy

In muscular dystrophies, muscle contraction with everyday movements causes muscle damage. Learn more about contraction-induced muscle damage and its role in disease progression.

Learn More About MD

Scientists. Physicians. Leaders.
Dedicated to Muscle Science.

Edgewise is dedicated to better understanding how complex physiologic muscle processes interact with disease pathologies in our bodies and the ways muscle plays a role in contributing to human health. We’re applying our knowledge across multiple disease states and, combined with our expertise in muscle physiology and small molecule drug design, we are making significant progress in developing new classes of muscle-targeted medicines. Our goal is to help people living with serious neuromuscular and cardiovascular diseases better manage their conditions—and live fuller, richer, and healthier lives.

Meet us

Footer

Edgewise Therapeutics
  • Disease Areas
  • Science
  • Patients & Families
  • Company
  • Investors & News

In the Clinic

We are advancing novel precision therapeutics for serious muscle disease.

Explore our pipeline

2025 © Copyright. Edgewise Therapeutics. All Rights Reserved.

  • Privacy Policy
  • Terms of Use
Facebook X, formally Twitter LinkedIn Instagram YouTube
logo
  • Company
    • Leadership Team
    • Careers
    • Contact Us
  • Science
    • Pipeline
    • Sevasemten
    • EDG-7500
    • EDG-15400
    • Clinical Trials
    • Posters & Presentations
  • Disease Areas
    • Muscular Dystrophy
    • Cardiovascular Diseases
  • Patients & Families
    • Support for Becker
    • Support for Duchenne
    • Support for HCM
    • Patient Stories
  • Investors & Media
    • Corporate Profile
    • News
    • Events & Presentations
    • Analyst Coverage
    • Stock Info
      • Stock Quote
      • Stock Chart
      • Historical Stock Quote
      • Investment Calculator
    • Financials
      • Quarterly Results
      • SEC Filings
    • Goverance
      • Governance Documents
      • Committee Composition
    • Resources
      • Investor FAQs
      • Investor Email Alerts
      • Investor Contacts